nimotuzumab
biocon,oncoscience,daiichi sankyo
['nimotuzumab']
nimotuzumab/placebo with gemcitabine in k-ras wilt type #pdac. data presented by dr quin. lba4011. #asco22 
Consultant in Medical Oncology with expertise in HPB and Neuroendocrine Tumours. Fundación Jiménez Díaz University Hospital. #BiliaryTractTumor #NET